Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type 1.

AUTOR(ES)

Yu, M

RESUMO

Successful treatment of human immunodeficiency virus infection may ultimately require targeting of hematopoietic stem cells. Here we used retroviral vectors carrying the ribozyme gene to transduce CD34+ cells from human fetal cord blood. Transduction and ribozyme expression had no apparent adverse effect on cell differentiation and/or proliferation. The macrophage-like cells, differentiated from the stem/progenitor cells in vitro, expressed the ribozyme gene and resisted infection by a macrophage tropic human immunodeficiency virus type 1. These results suggest the feasibility of stem cell gene therapy for human immunodeficiency virus-infected patients.

Documentos Relacionados

• Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells.
• Absent or rare human immunodeficiency virus infection of bone marrow stem/progenitor cells in vivo.
• In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
• The pattern of gene expression in human CD34+ stem/progenitor cells
• Regeneration of intestinal stem/progenitor cells following doxorubicin treatment of mice